US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 1.030
  • -0.040-3.74%
Close Mar 28 16:00 ET
  • 1.080
  • +0.050+4.85%
Post 16:05 ET
46.17MMarket Cap-0.63P/E (TTM)

Werewolf Therapeutics Key Stats

Werewolf Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 300.000K--
--2025/Q1-- / 300.000K--
--2024/Q40.000 / 301.590K--
--2024/Q30.000 / 709.320K--
--2024/Q21.143M / 841.780K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 300.000K--
--2025/Q1-- / 300.000K--
--2024/Q40.000 / 301.590K--
--2024/Q30.000 / 709.320K--
--2024/Q21.143M / 841.780K--

Unlock Free Earnings Estimates

Werewolf Therapeutics Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More